Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.raymedlab.com | |
Market Cap | 0.93 Cr. | |
Enterprise Value(EV) | 0.93 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -0.31 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.46 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | -5.52 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | -0.39 | Calculated using Price: 2.18 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.43 Cr. | 4,273,500 Shares |
FaceValue | 10 | |
About Raymed Labs Ltd. | ||
Raymed Labs was established in 1994 as a pharmaceutical company with emphasis on injectables with state of the art manufacturing facilities. the company is located at Dehradun Road, Saharanpur, UP. Manufacturing pharmaceutical products, as such, is a specialized job, however, manufacturing of injectables is even more difficult since they are normally given during a life saving situation thus their quality standards are much more stringent. Raymed's quality quickly won the trusts of doctors and it established itself as one of the leading quality manufacturers of medicines in the area. |
1 Day |
|
|
1 Week |
|
+4.81% |
1 Month |
|
+3.32% |
3 Month |
|
-11.38% |
6 Month |
|
-7.23% |
1 Year |
|
+6.86% |
2 Year |
|
+37.97% |
5 Year |
|
-4.80% |
10 Year |
|
-77.05% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Return on Capital Employed (%) | -7.11 | -15.55 | -26.39 | -41.34 | -58.42 | -105.49 | -94.35 | 0 | 0 | |
Return on Assets (%) | -6.08 | -12.9 | -17.98 | -20.71 | -20.01 | -21.34 | -27.07 | -32.96 | -85.07 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | |
Non Curr. Liab. | 2 | 2 | 2 | ||||||||
Curr. Liab. | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 0 | 0 | 0 | |
Minority Int. | |||||||||||
Equity & Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Non Curr. Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Curr. Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | |||||||||||
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
PBIDT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Interest | |||||||||||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Taxation | |||||||||||
Exceptional Items | 0 | 0 | 0 | 0 | |||||||
PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | -2 | 0 | ||||||
Cash Fr. Inv. | 0 | 2 | 0 | ||||||||
Cash Fr. Finan. | 0 | 0 | 0 | ||||||||
Net Change | 0 | ||||||||||
Cash & Cash Eqvt |
Sat, 23 Mar 2024
Closure of Trading Window Intimation for Closure of Trading Window for the Quarter ended 31 March 2024. |
Wed, 07 Feb 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication Intimation under Regulation 30 of SEBI LODR Regulation 2015 -Newspaper Publication |
Tue, 06 Feb 2024
Approval Of Unaduited Standalone Financial Result For The Quarter Ended 31St December 2023 Approval of Unaudited Stanalone Financial Result for the Quarter ended 31st December 2023 of Raymed Labs Limited |
Tue, 26 Mar 2024 |
Close Crossing Last Week High |
Close Crossing Last Month Close From Below |
Opening at High |
Opening at Low |
Closing Above Previous High |